Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
α1-Antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy
David A. Lomas, Ravi Mahadeva
David A. Lomas, Ravi Mahadeva
Published December 1, 2002
Citation Information: J Clin Invest. 2002;110(11):1585-1590. https://doi.org/10.1172/JCI16782.
View: Text | PDF
Perspective Article has an altmetric score of 6

α1-Antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy

  • Text
  • PDF
Abstract

Perspective

Authors

David A. Lomas, Ravi Mahadeva

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Inclusion formation in the serpinopathies. Z α1-antitrypsin is retained ...
Inclusion formation in the serpinopathies. Z α1-antitrypsin is retained within hepatocytes as intracellular inclusions, which are PAS-positive and diastase-resistant (a, arrow) and are associated with neonatal hepatitis and hepatocellular carcinoma. (c) Electron micrograph of a hepatocyte from the liver of a patient with Z α1-antitrypsin deficiency shows the accumulation of α1-antitrypsin within the rough endoplasmic reticulum. These inclusions are composed of chains of α1-antitrypsin polymers, shown here from the plasma of a Siiyama α1-antitrypsin homozygote (e) and from the liver of a Z α1-antitrypsin homozygote (f). Similar mutations in α1-antitrypsin deficiency and neuroserpin encephalopathy result in similar intracellular inclusions of α1-antitrypsin and neuroserpin. They are shown here in hepatocytes (a) and neurons (b) with PAS staining (arrow) and as endoplasmic aggregates of the abnormal proteins with electron microscopy (c, hepatocytes; d, neurons). Electron microscopy confirms that the abnormal neuroserpin forms beadlike polymers and entangled polymeric aggregates identical to those shown here with Z α1-antitrypsin (e and f, respectively). Magnification, left to right: ×200, ×20,000, ×220,000. Reproduced with permission from The New England Journal of Medicine (33).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 4 Wikipedia pages
Referenced in 1 clinical guideline sources
39 readers on Mendeley
See more details